Combined modality treatment in the management of high-risk prostate cancer

The efficacy of a multimodality protocol using neoadjuvant and concomitant hormonal therapy, brachytherapy, and three-dimensional conformal external beam radiotherapy (RT) in high-risk prostate cancer was evaluated using biochemical outcomes and posttreatment biopsy results. Between February 1994 an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of radiation oncology, biology, physics biology, physics, 2004-08, Vol.59 (5), p.1352-1359
Hauptverfasser:	Stock, Richard G, Cahlon, Oren, Cesaretti, Jamie A, Kollmeier, Marisa A, Stone, Nelson N
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen Antagonists - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Biological and medical sciences Brachytherapy Combined modality Combined Modality Therapy Finasteride - therapeutic use Flutamide - therapeutic use Gonadotropin-Releasing Hormone - agonists High risk Humans Locally advanced Male Medical sciences Palladium - therapeutic use Prostate cancer Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - drug therapy Prostatic Neoplasms - radiotherapy Radioisotopes - therapeutic use Radiotherapy, Conformal Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Technology. Biomaterials. Equipments. Material. Instrumentation Testosterone - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!